ERLOTINIB 25 mg/1 (Erlotinib TABLET, FILM COATED) 25 mg/1

Erlotinib 25 mg tablets are a targeted therapy used to treat certain types of cancer. This oral medication is designed to inhibit specific proteins that contribute to cancer cell growth.

Strength

25 mg/1

Pack Size

1 BOTTLE in 1 CARTON (31722-263-30) / 30 TABLET, FILM COATED in 1 BOTTLE

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Erlotinib is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by targeting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' and the answer lies in its ability to interfere with the signaling pathways that promote cancer cell proliferation.

Side Effects

Common effects of Erlotinib may include skin rash, diarrhea, and fatigue. Some patients also experience appetite loss and nausea. These effects can vary in intensity and may differ from person to person.

Precautions & Warnings

Erlotinib should be handled with care, as it is a potent medication. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or those taking other medications should discuss potential risks with their doctor.

Avoid Interactions

Erlotinib may interact with other medications, including those that are metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how Erlotinib works in the body.

Frequently Asked Questions

Erlotinib is used to treat certain types of cancer, such as non-small cell lung cancer and pancreatic cancer, by targeting specific proteins that contribute to cancer cell growth.

Erlotinib is typically taken orally, and the specific instructions for administration should be provided by a healthcare professional.

Common side effects of Erlotinib may include skin rash, diarrhea, fatigue, appetite loss, and nausea.

Erlotinib may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Patients should follow the advice of a healthcare professional and inform them of any medical conditions or other medications being taken.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.